Cleared Traditional

K012561 - VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-HCV CONTROLS (FDA 510(k) Clearance)

Aug 2001
Decision
21d
Days
Class 1
Risk

K012561 is an FDA 510(k) clearance for the VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-HCV CONTROLS. This device is classified as a Single (specified) Analyte Controls (assayed And Unassayed) (Class I - General Controls, product code JJX).

Submitted by Ortho-Clinical Diagnostics (Rochester, US). The FDA issued a Cleared decision on August 29, 2001, 21 days after receiving the submission on August 8, 2001.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 862.1660.

Submission Details

510(k) Number K012561 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 08, 2001
Decision Date August 29, 2001
Days to Decision 21 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code JJX — Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class I - General Controls
CFR Regulation 21 CFR 862.1660